Abstract
This article reports a MEMS (Micro-Electro-Mechanical-Systems)-based column separator designed for potential integration with portable medical point-of-care testing (POCT) devices. The MEMS column uses size exclusion chromatography (SEC) to pre-separate raw samples by size, and is made of polydimethylsiloxane (PDMS) fabricated on a glass slide. The MEMS SEC column separates 300 ng/mL of beta-human chorionic gonadotropin (β-hCG), a cancer biomarker, from a fibrinogen-rich solution (20 μg/mL) in 10 min, showing 2.12 resolution and 0.036 mm plate height through fluorescent detection. Results are further verified by β-hCG and anti-β-hCG antibody conjugate using surface plasmon resonance (SPR). The collected β-hCG-rich eluent at 8 min shows 11 mDeg of angle shift. The fluorescent detection and SPR results demonstrate the complete discrimination of β-hCG from fibrinogen using the MEMS SEC column, and illustrate its viability for integrating a sample preparation stage in POCT devices to assist cancer screening and prognosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
